Tapewire

Nasdaq · USD

IMVT

Immunovant, Inc.

Export transactions ↓
Tapewire entity
3632
SEC CIK
0001764013
Parsed reports
357

Last 12 months

Inside the activity.

1 purchase rows · 60 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202502
Dec 202516
Jan 202603
Feb 202603
Mar 202601
Apr 202608
May 202607
Jun 2026010
Jul 2026012
Aug 202602
Sep 202601
Oct 202605

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
April 12, 2023 Filed Apr 14, 2023 20:33 UTC GrantStock Option (right to buy) · Derivative 16,260 $0.00 Strike: $14.70 $0.00
Disclosure

SEC source: 0001764013-23-000045 · wf-form4_168150437013871.xml · derivative · entry 2

Fromkin Andrew J. · CIK 0001341896 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,260

Underlying: Common Stock · 16,260 shares

Expires 2033-04-12

F3 · derivative.exercise_date: The shares underlying the options vest one year after the date of grant on April 12, 2024, subject to the Reporting Person's continuous service to the Issuer as of such date.

Read SEC document
April 12, 2023 Filed Apr 14, 2023 20:33 UTC GrantCommon Stock 12,523 $0.00 $0.00
Disclosure

SEC source: 0001764013-23-000045 · wf-form4_168150437013871.xml · nonDerivative · entry 1

Fromkin Andrew J. · CIK 0001341896 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 101,008

F1 · security: Represents the number of shares underlying restricted stock units awards ("RSUs").

F2 · shares: The RSUs vest in their entirety one year after the date of grant on April 12, 2024, subject to the Reporting Person's continued service to the Issuer as of such date; provided that the Reporting Person may elect to defer settlement of the RSUs upon vesting, subject to the requirements of Rule 409A.

Read SEC document
April 12, 2023 Filed Apr 14, 2023 20:29 UTC
Torti FrankDirector
GrantStock Option (right to buy) · Derivative 158,292 $0.00 Strike: $14.70 $0.00
Disclosure

SEC source: 0001764013-23-000043 · wf-form4_168150413461709.xml · derivative · entry 2

Torti Frank · CIK 0001647805 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 158,292

Underlying: Common Stock · 158,292 shares

Expires 2033-04-12

F3 · derivative.exercise_date: Shares underlying the options vest over a period of two years, in a series of eight successive equal installments from the date of the award, subject to the Reporting Person providing continuous service to the Issuer as of each such date.

Read SEC document
April 12, 2023 Filed Apr 14, 2023 20:29 UTC
Torti FrankDirector
GrantCommon Stock 121,916 $0.00 $0.00
Disclosure

SEC source: 0001764013-23-000043 · wf-form4_168150413461709.xml · nonDerivative · entry 1

Torti Frank · CIK 0001647805 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 515,274

F1 · security: Represents the number of shares underlying restricted stock units awards ("RSUs").

F2 · shares: The RSUs vest over a period of two years, in a series of eight successive equal installments from the date of the award, subject to the Reporting Person providing continuous service to the Issuer as of each such date; provided that the Reporting Person may elect to defer settlement of the RSUs upon vesting, subject to the requirements of Rule 409A.

Read SEC document
April 12, 2023 Filed Apr 14, 2023 20:26 UTC
Butchko Julia G.Chief Dev. & Tech. Officer
GrantStock Option (right to buy) · Derivative 130,081 $0.00 Strike: $14.70 $0.00
Disclosure

SEC source: 0001764013-23-000042 · wf-form4_168150398782671.xml · derivative · entry 2

Butchko Julia G. · CIK 0001796290 · Chief Dev. & Tech. Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 130,081

Underlying: Common Stock · 130,081 shares

Expires 2033-04-12

F3 · derivative.exercise_date: Shares underlying the options vest over four years, with 25% of the shares underlying the options vesting on April 12, 2024 and the remainder of the shares underlying the options vesting in 36 equal monthly installments thereafter, subject to the Reporting Person providing continuous service to the Issuer as of each such date.

Read SEC document
April 12, 2023 Filed Apr 14, 2023 20:26 UTC
Butchko Julia G.Chief Dev. & Tech. Officer
GrantCommon Stock 100,188 $0.00 $0.00
Disclosure

SEC source: 0001764013-23-000042 · wf-form4_168150398782671.xml · nonDerivative · entry 1

Butchko Julia G. · CIK 0001796290 · Chief Dev. & Tech. Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 431,607

F1 · security: Represents the number of shares underlying restricted stock units awards ("RSUs").

F2 · shares: The RSUs vest over four years, with 25% of the RSUs vesting on April 12, 2024 and the remainder of the RSUs vesting in 12 equal quarterly installments thereafter, subject to the Reporting Person providing continuous service to the Issuer as of each such date.

Read SEC document
April 12, 2023 Filed Apr 14, 2023 20:24 UTC
Levine Mark S.Chief Legal Officer
GrantStock Option (right to buy) · Derivative 113,821 $0.00 Strike: $14.70 $0.00
Disclosure

SEC source: 0001764013-23-000041 · wf-form4_168150383601971.xml · derivative · entry 2

Levine Mark S. · CIK 0001617236 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 113,821

Underlying: Common Stock · 113,821 shares

Expires 2033-04-12

F3 · derivative.exercise_date: Shares underlying the options vest over four years, with 25% of the shares underlying the options vesting on April 12, 2024 and the remainder of the shares underlying the options vesting in 36 equal monthly installments thereafter, subject to the Reporting Person providing continuous service to the Issuer as of each such date.

Read SEC document
April 12, 2023 Filed Apr 14, 2023 20:24 UTC
Levine Mark S.Chief Legal Officer
GrantCommon Stock 87,664 $0.00 $0.00
Disclosure

SEC source: 0001764013-23-000041 · wf-form4_168150383601971.xml · nonDerivative · entry 1

Levine Mark S. · CIK 0001617236 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 333,324

F1 · security: Represents the number of shares underlying restricted stock units awards ("RSUs").

F2 · shares: The RSUs vest over four years, with 25% of the RSUs vesting on April 12, 2024 and the remainder of the RSUs vesting in 12 equal quarterly installments thereafter, subject to the Reporting Person providing continuous service to the Issuer as of each such date.

Read SEC document
April 12, 2023 Filed Apr 14, 2023 20:22 UTC
Barnett Eva ReneeChief Financial Officer
GrantStock Option (right to buy) · Derivative 113,821 $0.00 Strike: $14.70 $0.00
Disclosure

SEC source: 0001764013-23-000040 · wf-form4_168150372133037.xml · derivative · entry 2

Barnett Eva Renee · CIK 0001883766 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 113,821

Underlying: Common Stock · 113,821 shares

Expires 2033-04-12

F3 · derivative.exercise_date: Shares underlying the options vest over four years, with 25% of the shares underlying the options vesting on April 12, 2024 and the remainder of the shares underlying the options vesting in 36 equal monthly installments thereafter, subject to the Reporting Person providing continuous service to the Issuer as of each such date.

Read SEC document
April 12, 2023 Filed Apr 14, 2023 20:22 UTC
Barnett Eva ReneeChief Financial Officer
GrantCommon Stock 87,664 $0.00 $0.00
Disclosure

SEC source: 0001764013-23-000040 · wf-form4_168150372133037.xml · nonDerivative · entry 1

Barnett Eva Renee · CIK 0001883766 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 356,011

F1 · security: Represents the number of shares underlying restricted stock units awards ("RSUs").

F2 · shares: The RSUs vest over four years, with 25% of the RSUs vesting on April 12, 2024 and the remainder of the RSUs vesting in 12 equal quarterly installments thereafter, subject to the Reporting Person providing continuous service to the Issuer as of each such date.

Read SEC document
April 12, 2023 Filed Apr 14, 2023 20:14 UTC
Salzmann PeterDirector · Chief Executive Officer
GrantStock Option (right to buy) · Derivative 316,585 $0.00 Strike: $14.70 $0.00
Disclosure

SEC source: 0001764013-23-000038 · wf-form4_168150324964962.xml · derivative · entry 2

Salzmann Peter · CIK 0001796309 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 316,585

Underlying: Common Stock · 316,585 shares

Expires 2033-04-12

F3 · derivative.exercise_date: Shares underlying the options vest over four years, with 25% of the shares underlying the options vesting on April 12, 2024 and the remainder of the shares underlying the options vesting in 36 equal monthly installments thereafter, subject to the Reporting Person providing continuous service to the Issuer as of each such date.

Read SEC document
April 12, 2023 Filed Apr 14, 2023 20:14 UTC
Salzmann PeterDirector · Chief Executive Officer
GrantCommon Stock 243,832 $0.00 $0.00
Disclosure

SEC source: 0001764013-23-000038 · wf-form4_168150324964962.xml · nonDerivative · entry 1

Salzmann Peter · CIK 0001796309 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,237,764

F1 · security: Represents the number of shares underlying restricted stock units awards ("RSUs").

F2 · shares: The RSUs vest over four years, with 25% of the RSUs vesting on April 12, 2024 and the remainder of the RSUs vesting in 12 equal quarterly installments thereafter, subject to the Reporting Person providing continuous service to the Issuer as of each such date.

Read SEC document
February 02, 2023 Filed Feb 3, 2023 07:24 UTC
Macias William L.Chief Medical Officer
SaleCommon Stock 537 $18.24 $9,794.88
Disclosure

SEC source: 0001764013-23-000024 · wf-form4_167542704698516.xml · nonDerivative · entry 1

Macias William L. · CIK 0001864280 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 262,996

F1 · security: On June 11, 2021, the holder was granted 18,674 restricted stock units ("RSUs"), as previously reported on a Form 4 filed on June 15, 2021, of which 1,167 of these RSUs vested on January 13, 2023. Amounts reported herein represent shares sold by the holder solely to satisfy the holder's tax withholding obligation due in connection with the vesting and settlement of this tranche of the RSUs and do not represent a discretionary sale by the holder.

Read SEC document
January 26, 2023 Filed Jan 27, 2023 12:20 UTC
Levine Mark S.Chief Legal Officer
SaleCommon Stock 10,156 $18.51 $187,987.56
Disclosure

SEC source: 0001764013-23-000015 · wf-form4_167482200506238.xml · nonDerivative · entry 1

Levine Mark S. · CIK 0001617236 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 245,660

F1 · security: On January 28, 2022, the holder was granted 143,000 restricted stock units ("RSUs"), as previously reported on a Form 4 filed on January 31, 2022, of which 35,750 of these RSUs vested on January 19, 2023. Amounts reported herein represent shares sold by the holder solely to satisfy the holder's tax withholding obligation due in connection with the vesting and settlement of this tranche of the RSUs and do not represent a discretionary sale by the holder.

Read SEC document
January 11, 2023 Filed Jan 13, 2023 08:13 UTC
Macias William L.Chief Medical Officer
SaleCommon Stock 44,448 $16.75 $744,504.00
Disclosure

SEC source: 0001764013-23-000006 · wf-form4_167361559332752.xml · nonDerivative · entry 2

Macias William L. · CIK 0001864280 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 263,533

F1 · security: On November 5, 2021, the holder was granted 112,108 restricted stock units ("RSUs"), as previously reported on a Form 4 filed on November 9, 2021. These RSUs vested in their entirety on January 1, 2023. Amounts reported herein represent shares sold by the holder solely to satisfy the holder's tax withholding obligation due in connection with the vesting and settlement of these RSUs and do not represent a discretionary sale by the holder.

F3 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.30 - $16.80 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.

Read SEC document
January 11, 2023 Filed Jan 13, 2023 08:13 UTC
Macias William L.Chief Medical Officer
SaleCommon Stock 120 $15.11 $1,813.20
Disclosure

SEC source: 0001764013-23-000006 · wf-form4_167361559332752.xml · nonDerivative · entry 1

Macias William L. · CIK 0001864280 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 307,981

F1 · security: On November 5, 2021, the holder was granted 112,108 restricted stock units ("RSUs"), as previously reported on a Form 4 filed on November 9, 2021. These RSUs vested in their entirety on January 1, 2023. Amounts reported herein represent shares sold by the holder solely to satisfy the holder's tax withholding obligation due in connection with the vesting and settlement of these RSUs and do not represent a discretionary sale by the holder.

F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.06 - $15.15 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.

Read SEC document
January 11, 2023 Filed Jan 13, 2023 13:21 UTC
Salzmann PeterDirector · Chief Executive Officer
SaleCommon Stock 4,021 $16.80 $67,552.80
Disclosure

SEC source: 0001764013-23-000012 · wf-form4_167361610100577.xml · nonDerivative · entry 1

Salzmann Peter · CIK 0001796309 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 993,932

F1 · security: On March 19, 2021, the holder was granted 132,500 restricted stock units ("RSUs"), as previously reported on a Form 4 filed on March 23, 2021, of which 8,282 of these RSUs vested on January 1, 2023. Amounts reported herein represent shares sold by the holder solely to satisfy the holder's tax withholding obligation due in connection with the vesting and settlement of this tranche of the RSUs and do not represent a discretionary sale by the holder.

F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.76 - $16.80 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.

Read SEC document
January 11, 2023 Filed Jan 13, 2023 13:19 UTC
Butchko Julia G.Chief Dev. & Tech. Officer
SaleCommon Stock 60,471 $16.79 $1,015,308.09
Disclosure

SEC source: 0001764013-23-000010 · wf-form4_167361594694409.xml · nonDerivative · entry 2

Butchko Julia G. · CIK 0001796290 · Chief Dev. & Tech. Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 331,419

F1 · security: On March 19, 2021, the holder was granted 54,500 restricted stock units ("RSUs"), as previously reported on a Form 4 filed on March 23, 2021, of which 3,407 of these RSUs vested on January 1, 2023. On August 3, 2021, the holder was granted 285,306 RSUs, as previously reported on a Form 4 filed on August 4, 2021, of which the remaining 142,653 of these RSUs vested on January 1, 2023. Amounts reported herein represent shares sold by the holder solely to satisfy the holder's tax withholding obligations due in connection with the vesting and settlement of these tranches of the RSUs and do not represent a discretionary sale by the holder.

F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.68 - $16.80 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.

Read SEC document
January 11, 2023 Filed Jan 13, 2023 13:19 UTC
Butchko Julia G.Chief Dev. & Tech. Officer
SaleCommon Stock 19 $15.16 $288.04
Disclosure

SEC source: 0001764013-23-000010 · wf-form4_167361594694409.xml · nonDerivative · entry 1

Butchko Julia G. · CIK 0001796290 · Chief Dev. & Tech. Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 391,890

F1 · security: On March 19, 2021, the holder was granted 54,500 restricted stock units ("RSUs"), as previously reported on a Form 4 filed on March 23, 2021, of which 3,407 of these RSUs vested on January 1, 2023. On August 3, 2021, the holder was granted 285,306 RSUs, as previously reported on a Form 4 filed on August 4, 2021, of which the remaining 142,653 of these RSUs vested on January 1, 2023. Amounts reported herein represent shares sold by the holder solely to satisfy the holder's tax withholding obligations due in connection with the vesting and settlement of these tranches of the RSUs and do not represent a discretionary sale by the holder.

Read SEC document
January 11, 2023 Filed Jan 13, 2023 13:16 UTC
Barnett Eva ReneeChief Financial Officer
SaleCommon Stock 4,499 $16.75 $75,358.25
Disclosure

SEC source: 0001764013-23-000008 · wf-form4_167361579253284.xml · nonDerivative · entry 2

Barnett Eva Renee · CIK 0001883766 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 268,347

F1 · security: On October 15, 2021, the holder was granted 143,000 restricted stock units ("RSUs"), as previously reported on a Form 4 filed on October 18, 2021, of which 8,937 of these RSUs vested on January 4, 2023. Amounts reported herein represent shares sold by the holder solely to satisfy the holder's tax withholding obligation due in connection with the vesting and settlement of this tranche of the RSUs and do not represent a discretionary sale by the holder.

F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.31 - $16.80 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.

Read SEC document
January 11, 2023 Filed Jan 13, 2023 13:16 UTC
Barnett Eva ReneeChief Financial Officer
SaleCommon Stock 11 $15.15 $166.65
Disclosure

SEC source: 0001764013-23-000008 · wf-form4_167361579253284.xml · nonDerivative · entry 1

Barnett Eva Renee · CIK 0001883766 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 272,846

F1 · security: On October 15, 2021, the holder was granted 143,000 restricted stock units ("RSUs"), as previously reported on a Form 4 filed on October 18, 2021, of which 8,937 of these RSUs vested on January 4, 2023. Amounts reported herein represent shares sold by the holder solely to satisfy the holder's tax withholding obligation due in connection with the vesting and settlement of this tranche of the RSUs and do not represent a discretionary sale by the holder.

Read SEC document
October 21, 2022 Filed Oct 25, 2022 07:43 UTC
Macias William L.Chief Medical Officer
SaleCommon Stock 341 $9.67 $3,297.47
Disclosure

SEC source: 0001764013-22-000134 · wf-form4_166669817084362.xml · nonDerivative · entry 1

Macias William L. · CIK 0001864280 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 308,101

F1 · security: On June 11, 2021, the holder was granted 18,674 restricted stock units ("RSUs"), as previously reported on a Form 4 filed on June 15, 2021, of which 1,167 of these RSUs vested on October 13, 2022. Amounts reported herein represent shares sold by the holder solely to satisfy the holder's tax withholding obligation due in connection with the vesting and settlement of this tranche of the RSUs and do not represent a discretionary sale by the holder.

Read SEC document
October 13, 2022 Filed Oct 17, 2022 12:59 UTC
Butchko Julia G.Chief Dev. & Tech. Officer
SaleCommon Stock 928 $9.18 $8,519.04
Disclosure

SEC source: 0001764013-22-000132 · wf-form4_166601156720429.xml · nonDerivative · entry 1

Butchko Julia G. · CIK 0001796290 · Chief Dev. & Tech. Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 391,909

F1 · security: On March 19, 2021, the holder was granted 54,500 restricted stock units ("RSUs"), as previously reported on a Form 4 filed on March 23, 2021, of which 3,406 of these RSUs vested on October 1, 2022 and the remainder of the RSUs vest in quarterly installments thereafter, subject to the Reporting Person providing continuous service to the Issuer as of each such date. Amounts reported herein represent shares sold by the holder solely to satisfy the holder's tax withholding obligation due in connection with the vesting and settlement of this tranche of the RSUs and do not represent a discretionary sale by the holder.

F2 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $9.18 - $9.26 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote to this Form 4.

Read SEC document
October 13, 2022 Filed Oct 17, 2022 12:57 UTC
Salzmann PeterDirector · Chief Executive Officer
SaleCommon Stock 2,793 $9.18 $25,639.74
Disclosure

SEC source: 0001764013-22-000130 · wf-form4_166601145413186.xml · nonDerivative · entry 1

Salzmann Peter · CIK 0001796309 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 997,953

F1 · security: On March 19, 2021, the holder was granted 132,500 restricted stock units ("RSUs"), as previously reported on a Form 4 filed on March 23, 2021, of which 8,281 of these RSUs vested on October 1, 2022 and the remainder of the RSUs vest in quarterly installments thereafter, subject to the Reporting Person providing continuous service to the Issuer as of each such date. Amounts reported herein represent shares sold by the holder solely to satisfy the holder's tax withholding obligation due in connection with the vesting and settlement of this tranche of the RSUs and do not represent a discretionary sale by the holder.

F2 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $9.18 - $9.22 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote to this Form 4.

Read SEC document
October 11, 2022 Filed Oct 13, 2022 20:20 UTC
Barnett Eva ReneeChief Financial Officer
SaleCommon Stock 12,500 $9.44 $118,000.00
Disclosure

SEC source: 0001764013-22-000128 · wf-form4_166569241491854.xml · nonDerivative · entry 1

Barnett Eva Renee · CIK 0001883766 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 272,857

F1 · security: On October 15, 2021, the holder was granted 143,000 restricted stock units ("RSUs"), as previously reported on a Form 4 filed on October 18, 2021, of which 25% of these RSUs vested on October 4, 2022. Amounts reported herein represent shares sold by the holder solely to satisfy the holder's tax withholding obligation due in connection with the vesting and settlement of this tranche of the RSUs.

F2 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $9.16 - $9.44 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote to this Form 4.

Read SEC document
October 06, 2022 Filed Oct 7, 2022 20:32 UTC PurchaseCommon Stock, $0.0001 par value per share 416,667 $6.00 $2,500,002.00
Disclosure

SEC source: 0001140361-22-036652 · form4.xml · nonDerivative · entry 1

Roivant Sciences Ltd. · CIK 0001635088 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 73,805,331

Read SEC document
September 30, 2022 Filed Oct 4, 2022 20:27 UTC
Pande AtulDirector
PurchaseCommon Stock 15,000 $5.60 $84,000.00
Disclosure

SEC source: 0001764013-22-000126 · wf-form4_166491518472332.xml · nonDerivative · entry 1

Pande Atul · CIK 0001643071 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By Trust

Disclosed balance after: 20,000

F1 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.59 - $5.61 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote to this Form 4.

F2 · ownership.nature: These shares are owned by a trust (the "Trust"). Certain members of the Reporting Person's immediate family are beneficiaries of the Trust.

Read SEC document
September 29, 2022 Filed Sep 29, 2022 20:21 UTC
Torti FrankDirector
PurchaseCommon Stock 20,000 $5.81 $116,200.00
Disclosure

SEC source: 0001764013-22-000120 · wf-form4_166448284375026.xml · nonDerivative · entry 1

Torti Frank · CIK 0001647805 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 393,358

F1 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.68 - $5.88 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote to this Form 4.

Read SEC document
September 28, 2022 Filed Sep 29, 2022 21:09 UTC
Butchko Julia G.Chief Dev. & Tech. Officer
SaleCommon Stock 535 $4.67 $2,498.45
Disclosure

SEC source: 0001764013-22-000124 · wf-form4_166448577616322.xml · nonDerivative · entry 1

Butchko Julia G. · CIK 0001796290 · Chief Dev. & Tech. Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 392,837

F1 · security: On March 19, 2021, the holder was granted 54,500 restricted stock units ("RSUs"), as previously reported on a Form 4 filed on March 23, 2021, of which 1,135 of these RSUs vested on September 19, 2022. Amounts reported herein represent shares sold by the holder solely to satisfy the holder's tax withholding obligation due in connection with the vesting and settlement of this tranche of the RSUs and do not represent a discretionary sale by the holder.

Read SEC document
September 28, 2022 Filed Sep 29, 2022 21:06 UTC
Salzmann PeterDirector · Chief Executive Officer
SaleCommon Stock 1,605 $4.67 $7,495.35
Disclosure

SEC source: 0001764013-22-000122 · wf-form4_166448557706339.xml · nonDerivative · entry 1

Salzmann Peter · CIK 0001796309 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,000,746

F1 · security: On March 19, 2021, the holder was granted 132,500 restricted stock units ("RSUs"), as previously reported on a Form 4 filed on March 23, 2021, of which 2,760 of these RSUs vested on September 19, 2022. Amounts reported herein represent shares sold by the holder solely to satisfy the holder's tax withholding obligation due in connection with the vesting and settlement of this tranche of the RSUs and do not represent a discretionary sale by the holder.

Read SEC document
August 30, 2022 Filed Sep 1, 2022 11:36 UTC
Salzmann PeterDirector · Chief Executive Officer
SaleCommon Stock 1,644 $5.83 $9,584.52
Disclosure

SEC source: 0001764013-22-000112 · wf-form4_166203216200949.xml · nonDerivative · entry 1

Salzmann Peter · CIK 0001796309 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,002,351

F1 · security: On March 19, 2021, the holder was granted 132,500 restricted stock units ("RSUs"), as previously reported on a Form 4 filed on March 23, 2021, of which 2,761 of these RSUs vested on August 19, 2022. Amounts reported herein represent shares sold by the holder solely to satisfy the holder's tax withholding obligation due in connection with the vesting and settlement of this tranche of the RSUs and do not represent a discretionary sale by the holder.

Read SEC document
August 30, 2022 Filed Sep 1, 2022 11:33 UTC
Butchko Julia G.Chief Dev. & Tech. Officer
SaleCommon Stock 548 $5.83 $3,194.84
Disclosure

SEC source: 0001764013-22-000111 · wf-form4_166203199206250.xml · nonDerivative · entry 1

Butchko Julia G. · CIK 0001796290 · Chief Dev. & Tech. Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 393,372

F1 · security: On March 19, 2021, the holder was granted 54,500 restricted stock units ("RSUs"), as previously reported on a Form 4 filed on March 23, 2021, of which 1,136 of these RSUs vested on August 19, 2022. Amounts reported herein represent shares sold by the holder solely to satisfy the holder's tax withholding obligation due in connection with the vesting and settlement of this tranche of the RSUs and do not represent a discretionary sale by the holder.

Read SEC document
August 17, 2022 Filed Aug 19, 2022 20:44 UTC GrantStock Option (right to buy) · Derivative 31,668 $0.00 Strike: $4.99 $0.00
Disclosure

SEC source: 0001764013-22-000093 · wf-form4_166094182912795.xml · derivative · entry 2

MIGAUSKY GEORGE V · CIK 0001134365 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 31,668

Underlying: Common Stock · 31,668 shares

Expires 2032-08-17

F3 · derivative.exercise_date: The shares underlying the options vest one year after the date of grant on August 17, 2023, subject to the Reporting Person's continuous service to the Issuer as of such date.

Read SEC document
August 17, 2022 Filed Aug 19, 2022 20:44 UTC GrantCommon Stock 21,059 $0.00 $0.00
Disclosure

SEC source: 0001764013-22-000093 · wf-form4_166094182912795.xml · nonDerivative · entry 1

MIGAUSKY GEORGE V · CIK 0001134365 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 109,985

F1 · security: Represents the number of shares underlying restricted stock units awards ("RSUs").

F2 · shares: The RSUs vest in their entirety one year after the date of grant on August 17, 2023, subject to the Reporting Person's continued service to the Issuer as of such date; provided that the Reporting Person may elect to defer settlement of the RSUs upon vesting, subject to the requirements of Rule 409A.

Read SEC document
August 17, 2022 Filed Aug 19, 2022 16:56 UTC
Macias William L.Chief Medical Officer
GrantStock Option (right to buy) · Derivative 169,648 $0.00 Strike: $4.99 $0.00
Disclosure

SEC source: 0001764013-22-000105 · wf-form4_166094256286794.xml · derivative · entry 2

Macias William L. · CIK 0001864280 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 169,648

Underlying: Common Stock · 169,648 shares

Expires 2032-08-17

F3 · derivative.exercise_date: Shares underlying the options vest over four years, with 25% of the shares underlying the options vesting on August 17, 2023 and the remainder of the shares underlying the options vesting in 36 equal monthly installments thereafter, subject to the Reporting Person providing continuous service to the Issuer as of each such date.

Read SEC document
August 17, 2022 Filed Aug 19, 2022 16:56 UTC
Macias William L.Chief Medical Officer
GrantCommon Stock 112,816 $0.00 $0.00
Disclosure

SEC source: 0001764013-22-000105 · wf-form4_166094256286794.xml · nonDerivative · entry 1

Macias William L. · CIK 0001864280 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 308,442

F1 · security: Represents the number of shares underlying restricted stock units awards ("RSUs").

F2 · shares: The RSUs vest over four years, with 25% of the RSUs vesting on August 17, 2023 and the remainder of the RSUs vesting in 12 equal quarterly installments thereafter, subject to the Reporting Person providing continuous service to the Issuer as of each such date.

Read SEC document
August 17, 2022 Filed Aug 19, 2022 20:57 UTC
Levine Mark S.Chief Legal Officer
GrantStock Option (right to buy) · Derivative 169,648 $0.00 Strike: $4.99 $0.00
Disclosure

SEC source: 0001764013-22-000107 · wf-form4_166094266063739.xml · derivative · entry 2

Levine Mark S. · CIK 0001617236 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 169,648

Underlying: Common Stock · 169,648 shares

Expires 2032-08-17

F3 · derivative.exercise_date: Shares underlying the options vest over four years, with 25% of the shares underlying the options vesting on August 17, 2023 and the remainder of the shares underlying the options vesting in 36 equal monthly installments thereafter, subject to the Reporting Person providing continuous service to the Issuer as of each such date.

Read SEC document
August 17, 2022 Filed Aug 19, 2022 20:57 UTC
Levine Mark S.Chief Legal Officer
GrantCommon Stock 112,816 $0.00 $0.00
Disclosure

SEC source: 0001764013-22-000107 · wf-form4_166094266063739.xml · nonDerivative · entry 1

Levine Mark S. · CIK 0001617236 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 255,816

F1 · security: Represents the number of shares underlying restricted stock units awards ("RSUs").

F2 · shares: The RSUs vest over four years, with 25% of the RSUs vesting on August 17, 2023 and the remainder of the RSUs vesting in 12 equal quarterly installments thereafter, subject to the Reporting Person providing continuous service to the Issuer as of each such date.

Read SEC document
August 17, 2022 Filed Aug 19, 2022 20:54 UTC
Butchko Julia G.Chief Dev. & Tech. Officer
GrantStock Option (right to buy) · Derivative 169,648 $0.00 Strike: $4.99 $0.00
Disclosure

SEC source: 0001764013-22-000103 · wf-form4_166094246284096.xml · derivative · entry 2

Butchko Julia G. · CIK 0001796290 · Chief Dev. & Tech. Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 169,648

Underlying: Common Stock · 169,648 shares

Expires 2032-08-17

F3 · derivative.exercise_date: Shares underlying the options vest over four years, with 25% of the shares underlying the options vesting on August 17, 2023 and the remainder of the shares underlying the options vesting in 36 equal monthly installments thereafter, subject to the Reporting Person providing continuous service to the Issuer as of each such date.

Read SEC document
August 17, 2022 Filed Aug 19, 2022 20:54 UTC
Butchko Julia G.Chief Dev. & Tech. Officer
GrantCommon Stock 112,816 $0.00 $0.00
Disclosure

SEC source: 0001764013-22-000103 · wf-form4_166094246284096.xml · nonDerivative · entry 1

Butchko Julia G. · CIK 0001796290 · Chief Dev. & Tech. Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 393,920

F1 · security: Represents the number of shares underlying restricted stock units awards ("RSUs").

F2 · shares: The RSUs vest over four years, with 25% of the RSUs vesting on August 17, 2023 and the remainder of the RSUs vesting in 12 equal quarterly installments thereafter, subject to the Reporting Person providing continuous service to the Issuer as of each such date.

Read SEC document
August 17, 2022 Filed Aug 19, 2022 20:52 UTC
Barnett Eva ReneeChief Financial Officer
GrantStock Option (right to buy) · Derivative 169,648 $0.00 Strike: $4.99 $0.00
Disclosure

SEC source: 0001764013-22-000101 · wf-form4_166094233293811.xml · derivative · entry 2

Barnett Eva Renee · CIK 0001883766 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 169,648

Underlying: Common Stock · 169,648 shares

Expires 2032-08-17

F3 · derivative.exercise_date: Shares underlying the options vest over four years, with 25% of the shares underlying the options vesting on August 17, 2023 and the remainder of the shares underlying the options vesting in 36 equal monthly installments thereafter, subject to the Reporting Person providing continuous service to the Issuer as of each such date.

Read SEC document
August 17, 2022 Filed Aug 19, 2022 20:52 UTC
Barnett Eva ReneeChief Financial Officer
GrantCommon Stock 112,816 $0.00 $0.00
Disclosure

SEC source: 0001764013-22-000101 · wf-form4_166094233293811.xml · nonDerivative · entry 1

Barnett Eva Renee · CIK 0001883766 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 285,357

F1 · security: Represents the number of shares underlying restricted stock units awards ("RSUs").

F2 · shares: The RSUs vest over four years, with 25% of the RSUs vesting on August 17, 2023 and the remainder of the RSUs vesting in 12 equal quarterly installments thereafter, subject to the Reporting Person providing continuous service to the Issuer as of each such date.

Read SEC document
August 17, 2022 Filed Aug 19, 2022 20:50 UTC
Salzmann PeterDirector · Chief Executive Officer
GrantStock Option (right to buy) · Derivative 678,592 $0.00 Strike: $4.99 $0.00
Disclosure

SEC source: 0001764013-22-000099 · wf-form4_166094221021747.xml · derivative · entry 2

Salzmann Peter · CIK 0001796309 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 678,592

Underlying: Common Stock · 678,592 shares

Expires 2032-08-17

F3 · derivative.exercise_date: Shares underlying the options vest over four years, with 25% of the shares underlying the options vesting on August 17, 2023 and the remainder of the shares underlying the options vesting in 36 equal monthly installments thereafter, subject to the Reporting Person providing continuous service to the Issuer as of each such date.

Read SEC document
August 17, 2022 Filed Aug 19, 2022 20:50 UTC
Salzmann PeterDirector · Chief Executive Officer
GrantCommon Stock 451,264 $0.00 $0.00
Disclosure

SEC source: 0001764013-22-000099 · wf-form4_166094221021747.xml · nonDerivative · entry 1

Salzmann Peter · CIK 0001796309 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,003,995

F1 · security: Represents the number of shares underlying restricted stock units awards ("RSUs").

F2 · shares: The RSUs vest over four years, with 25% of the RSUs vesting on August 17, 2023 and the remainder of the RSUs vesting in 12 equal quarterly installments thereafter, subject to the Reporting Person providing continuous service to the Issuer as of each such date.

Read SEC document
August 17, 2022 Filed Aug 19, 2022 20:48 UTC GrantStock Option (right to buy) · Derivative 31,668 $0.00 Strike: $4.99 $0.00
Disclosure

SEC source: 0001764013-22-000097 · wf-form4_166094208760439.xml · derivative · entry 2

Fromkin Andrew J. · CIK 0001341896 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 31,668

Underlying: Common Stock · 31,668 shares

Expires 2032-08-17

F3 · derivative.exercise_date: The shares underlying the options vest one year after the date of grant on August 17, 2023, subject to the Reporting Person's continuous service to the Issuer as of such date.

Read SEC document
August 17, 2022 Filed Aug 19, 2022 20:48 UTC GrantCommon Stock 21,059 $0.00 $0.00
Disclosure

SEC source: 0001764013-22-000097 · wf-form4_166094208760439.xml · nonDerivative · entry 1

Fromkin Andrew J. · CIK 0001341896 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 88,485

F1 · security: Represents the number of shares underlying restricted stock units awards ("RSUs").

F2 · shares: The RSUs vest in their entirety one year after the date of grant on August 17, 2023, subject to the Reporting Person's continued service to the Issuer as of such date; provided that the Reporting Person may elect to defer settlement of the RSUs upon vesting, subject to the requirements of Rule 409A.

Read SEC document
August 17, 2022 Filed Aug 19, 2022 20:46 UTC
Pande AtulDirector
GrantStock Option (right to buy) · Derivative 31,668 $0.00 Strike: $4.99 $0.00
Disclosure

SEC source: 0001764013-22-000095 · wf-form4_166094195240810.xml · derivative · entry 2

Pande Atul · CIK 0001643071 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 31,668

Underlying: Common Stock · 31,668 shares

Expires 2032-08-17

F3 · derivative.exercise_date: The shares underlying the options vest one year after the date of grant on August 17, 2023, subject to the Reporting Person's continuous service to the Issuer as of such date.

Read SEC document
August 17, 2022 Filed Aug 19, 2022 20:46 UTC
Pande AtulDirector
GrantCommon Stock 21,059 $0.00 $0.00
Disclosure

SEC source: 0001764013-22-000095 · wf-form4_166094195240810.xml · nonDerivative · entry 1

Pande Atul · CIK 0001643071 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 82,985

F1 · security: Represents the number of shares underlying restricted stock units awards ("RSUs").

F2 · shares: The RSUs vest in their entirety one year after the date of grant on August 17, 2023, subject to the Reporting Person's continued service to the Issuer as of such date; provided that the Reporting Person may elect to defer settlement of the RSUs upon vesting, subject to the requirements of Rule 409A.

Read SEC document
August 17, 2022 Filed Aug 19, 2022 20:41 UTC GrantStock Option (right to buy) · Derivative 31,668 $0.00 Strike: $4.99 $0.00
Disclosure

SEC source: 0001764013-22-000091 · wf-form4_166094167115623.xml · derivative · entry 2

Hughes Douglas J. · CIK 0001710863 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 31,668

Underlying: Common Stock · 31,668 shares

Expires 2032-08-17

F3 · derivative.exercise_date: The shares underlying the options vest one year after the date of grant on August 17, 2023, subject to the Reporting Person's continuous service to the Issuer as of such date.

Read SEC document
August 17, 2022 Filed Aug 19, 2022 20:41 UTC GrantCommon Stock 21,059 $0.00 $0.00
Disclosure

SEC source: 0001764013-22-000091 · wf-form4_166094167115623.xml · nonDerivative · entry 1

Hughes Douglas J. · CIK 0001710863 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 101,232

F1 · security: Represents the number of shares underlying restricted stock units awards ("RSUs").

F2 · shares: The RSUs vest in their entirety one year after the date of grant on August 17, 2023, subject to the Reporting Person's continued service to the Issuer as of such date; provided that the Reporting Person may elect to defer settlement of the RSUs upon vesting, subject to the requirements of Rule 409A.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.